Scisparc Ltd. - Early Warning Regarding Acquisition Of Common Shares Of Neurothera Labs Inc.

Core Points - SciSparc Ltd. has completed a reverse takeover of NeuroThera Labs Inc., acquiring significant shares and rights in the process [2][4] - The transaction involved the acquisition of 63,300,000 common shares, 4,000,000 common share purchase warrants, and 48,000,000 contingent rights [2][4] - Following the transaction, SciSparc holds approximately 75% of the issued shares on a non-diluted basis and 84.53% on a partially diluted basis [4] Summary by Sections Acquisition Details - SciSparc acquired 63,300,000 common shares, 4,000,000 payment warrants, and 48,000,000 contingent rights of NeuroThera Labs Inc. as part of a qualifying transaction [2][4] - The payment warrants allow SciSparc to purchase additional common shares at $0.25 each until October 22, 2030 [3] Ownership Structure - Prior to the transaction, SciSparc did not hold any shares in NeuroThera Labs Inc. [4] - The deemed value of the acquired common shares is $0.25 per share [4] Future Intentions - SciSparc's holdings in NeuroThera Labs Inc. are for investment purposes, with no current plans to acquire or dispose of additional securities [5]